An interventional study of Whole-body vibration (WBV) in Body Weight, Vibration and Motor Activity, sponsored by Universidad Rey Juan Carlos. Completed at 1 site in Spain. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-11-28.
Sponsored by Universidad Rey Juan Carlos · Not applicable, Interventional, and Treatment
Among 22 studies in Body Weight with a site in Spain — 7 open to participants now, 10 under way, 3 of them phase 3. Body Weight · Spain.
Among the 22 studies in Body Weight with a site in Spain, this one is the 14th largest by enrollment of the 17 interventional ones that give a count, is the only one that started in 2017, is one of 11 with no phase, and was the 6th registered.
657 studies on the registry are indexed under Body Weight; 76 are open to participants now.
Browse Body Weight studies →7 of the 22 studies in Body Weight with a site in Spain are open now. Recruiting first, the newest first:
Pfizer · Sites in Spain, United States, Brazil and 8 more countries
IMDEA Food · Sites in Spain
Universidad de Córdoba · Sites in Spain
Universidad Complutense de Madrid · Sites in Spain
University of Alicante · Sites in Spain
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 51 Body Weight studies recruiting now, 20 (39%) set no upper age limit and 29 (57%) stop at 75 or younger; 6 take children under 18; 16 take healthy volunteers.
This study: 18 Years to 30 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 1 started in 2017.
This study's enrollment of 38 is below the median of 71 across 500 interventional studies indexed under Body Weight.
Median enrollment 84 across the 17 interventional studies, 214 across the 5 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 22 have an industry lead sponsor. The 10 most frequent:
Universidad Rey Juan Carlos is the lead sponsor of 114 studies on the registry; 24 are open to participants now.
Universidad Rey Juan Carlos has 1 study filed under Body Weight — fewer than ten, so there is no comparison to draw.
4 of the studies in Body Weight with a site in Spain that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06858839Phase 3AmgenEvaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight | 2027-01-21 |
| NCT07400653Phase 3PfizerA Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) | 2027-10-12 |
| NCT06409962Universidad de CórdobaA New Technological Intervention to Address Childhood Obesity: | 2026-12-12 |
| NCT06857929IMDEA Food"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" | 2027-09-30 |
Among the 22 studies in Body Weight with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Purpose: To evaluate the short-term effects of whole-body vibration (WBV), using reciprocating plate technique, on manual ability performance in healthy younger.
Material and methods: 38 healthy young volunteers were randomized to WBV group (N=19; 6 men, 13 women; mean age 21, 3.8yrs) or control group (N=19; 6 men, 13 women; mean age 20.5, 3.5yrs). The subjects in the WBV group performed one series of five consecutive repetitions of 60 sec unsynchronised WBV (Zeptoring, Scisen GmbH, Germany; 4 Hz, amplitude 3mm) with a 1-min pause between administrations, three times a week. The controls did not receive any training. Both groups were evaluated at baseline and after intervention, in the Rey Juan Carlos University´s Gait Analysis Laboratory. Four outcome measures of Purdue Pegboard test (PPT): preferred hand (PH), non-preferred hand (NPH), both hands (BH) and assembly (A) was performed baseline and 5 min after intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The subjects in the WBV group performed one series of five consecutive repetitions of 60 sec unsynchronised multidimensional WBV (Zeptoring, Scisen GmbH, Germany; 4 Hz, amplitude 3mm) with a 1-min pause between administrations, three times a week. The construction of this device is designed to perform a nonharmonious generation of oscillating movements in vertical and horizontal planes in order to prevent occurrences of resonance and habituation of receptors. During the intervention, subjects wore thin-soled gymnastic-type shoes, carrying out in a squatting standing position, with slight flexion at the hips, knees and ankle joint, on the vibration platform.
Device: Whole-body vibration (WBV)
The controls did not receive any training.
Whole-body vibration (WBV) is a novel neuromuscular therapeutic intervention that has recently been developed since in the mid-1960s. Hagbart and Eklund showed in human experiments that a reflex muscle contraction can result as a consequence of applying vibrations to the muscular-tendon system. The subjects stand on a platform that generates stochastic vibrations at a frequency between 1-12.5 Hz.
Purdue Pegboard test (change)
Change in Purdue Pegboard test. This tool evaluates the fine dexterity
Time frame: Baseline, immediately after intervention and one month after the intervention
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Jul 2017 to primary completion in Aug 2017, 1 month.
Of 206 non-industry interventional studies with no phase under Body Weight, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 40. This study's 1 month is below that.
Counting every sponsor, half of 226 studies reached it within 18 months; a quarter within 7 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.